Javascript message
This site uses javascript. If javascript is disabled in your browser, some functionality may be impaired.
Strategies for efficient purification of single and dual receptor agonists using Kromasil® chromatography media
In this technical webinar, Dr. Marziyeh Ghaeidamini, Scientist in the Kromasil® team at Nouryon, will present a powerful and scalable purification strategy for GLP-1/incretin receptor agonists such as semaglutide, liraglutide, and tirzepatide. The method is based on preparative reversed-phase chromatography and refined through stationary phase screening across different solvent systems, combined with a mild CIP (clean-in-place) procedure that significantly extends column lifetime and reduces operational costs.
If you are working with peptide purification or are interested in improving process efficiency, this session will offer valuable insights into how Kromasil® stationary phases support both current and next-generation peptide therapeutics.
Pick your session and register
Two sessions are offered for a wider audience worldwide.
- Date: November 13th, 2025
- Place: Online event
- Duration: 45 min, including Q&A
- Sessions:
Session 1: Loading time...
Register for session 1Session 2: Loading time...
Register for session 2Display session times in a timezone near you:
Heads up: Times for session 2 that display
as AM times are next day, November 14th.
About the speaker
Marziyeh Ghaeidamini holds a PhD in biology and is an accomplished scientist with extensive experience in protein chemistry, cell biology, and biochemistry. She works as a Scientist in the Kromasil® team at Nouryon, focusing on the development of purification methods for various peptides and the optimization of cleaning-in-place (CIP) procedures for different stationary phases employed in reverse phase chromatography.
Top image: GLP-1 receptor (blue) across cell lipid membrane and tirzepatide (red) in separated and activated configurations.